Entrada Therapeutics, Inc. (TRDA)
Entrada Therapeutics Market Cap : 457.88M for March 27, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Tyra Biosciences, Inc. | 1.955B |
| EyePoint Plc | 1.041B |
| Vertex Pharmaceuticals, Inc. | 110.00B |
| Kodiak Sciences, Inc. | 2.262B |
| Arcutis Biotherapeutics, Inc. | 2.631B |
Market Cap Related Metrics
| PS Ratio | 19.46 |
| Price to Book Value | 1.496 |
| Price | 11.96 |
| Earnings Yield | -29.02% |